--- Advertisement -Nigerian doctor in U.S. Babafemi Taiwo Is Leading Major Study on Remdesivir COVID-19 Drug
A bright doctor from the West African country of Nigeria Babafemi Taiwo is leading part of a major study on antiviral drug Remdesivir appearing to treat COVID-19, the potentially deadly respiratory disease caused by the coronavirus, which has killed more than 200,000 people around the world.
CNN interviewed Dr. Taiwo, whose name suggests he is a twin from the southwestern part of Nigeria, to discuss the promising results. Remdesivir, the antiviral drug made by Gilead Sciences, appears to help coronavirus patients recover more quickly than no treatment at all, but it does not significantly reduce death, according to preliminary data from the National
"For the first time we have a large, well-conducted trial" showing a treatment helps, he said. "This is not a miracle drug … but it's definitely better than anything we have."
Fauci said the partial results showed that the drug had "a clear-cut significant positive effect," shortening the time to hospital discharge by four days. By comparison, antiviral drugs for the flu shorten illness by about one day on average and only when started within a day or two of symptoms first appearing.
Must Read: Bill Gates: COVID-19 vaccine coming sooner than later
In the remdesivir study, about 8% of those on the drug died versus 11.6% of the comparison group, but the difference is not large enough for scientists to say the drug was the reason.
No information was given on side effects. Fauci said full results would be published in a medical journal soon. He said final numbers might change a bit but that the study's overall conclusion would not.
Dr. BABAFEMI TAIWO PROFILE
Dr. Babafemi Taiwo is Chief, Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago. He is also Director, Clinical Core of the Third Coast Center for AIDS Research, and Leader of the Northwestern University Site of the NIAID-funded AIDS Clinical Trials Group (ACTG). At Northwestern University, he leads clinical and translational HIV researchers from infectious diseases, hepatology, neurology, radiology, cardiology and nursing, and directs the development and implementation of NIH-sponsored interventional and observational HIV studies.
He has received research grants (to Northwestern) from industry sponsors for investigator-initiated studies. Dr. Taiwo is the Director, Research in Africa, NU Center for Global Health. He has been involved in HIV treatment, research, and training in Nigeria for two decades. His undergraduate education and initial medical training took place at the College of Medicine, University of Ibadan 1991. He is Principal Investigator of the NIH D43 Multidisciplinary NeuroAIDS Training and Research Program in Nigeria
Farooq A. Kperogi, Ph.D.School of Communication & MediaSocial Science BuildingRoom 5092 MD 2207402 Bartow Avenue
Kennesaw State UniversityKennesaw, Georgia, USA 30144
Cell: (+1) 404-573-9697
Personal website: www.farooqkperogi.comTwitter: @farooqkperogiNigeria's Digital Diaspora: Citizen Media, Democracy, and Participation
"The nice thing about pessimism is that you are constantly being either proven right or pleasantly surprised." G. F. Will
Listserv moderated by Toyin Falola, University of Texas at Austin
To post to this group, send an email to USAAfricaDialogue@googlegroups.com
To subscribe to this group, send an email to USAAfricaDialogue+subscribe@googlegroups.com
Current archives at http://groups.google.com/group/USAAfricaDialogue
Early archives at http://www.utexas.edu/conferences/africa/ads/index.html
---
You received this message because you are subscribed to the Google Groups "USA Africa Dialogue Series" group.
To unsubscribe from this group and stop receiving emails from it, send an email to usaafricadialogue+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/usaafricadialogue/CAPq-FWvWv2FiPDP4R3unnVByV618m_%2BAG89_EgbV%3DZBg84QPdQ%40mail.gmail.com.
Listserv moderated by Toyin Falola, University of Texas at Austin
To post to this group, send an email to USAAfricaDialogue@googlegroups.com
To subscribe to this group, send an email to USAAfricaDialogue+subscribe@googlegroups.com
Current archives at http://groups.google.com/group/USAAfricaDialogue
Early archives at http://www.utexas.edu/conferences/africa/ads/index.html
---
You received this message because you are subscribed to the Google Groups "USA Africa Dialogue Series" group.
To unsubscribe from this group and stop receiving emails from it, send an email to usaafricadialogue+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/usaafricadialogue/CAN_y-4pLqkP%2BVPRbQK2rVuzWVOXYFherDBRS47t%2B-1sKJTnO7A%40mail.gmail.com.
No comments:
Post a Comment